Insulin effects in muscle and adipose tissue
George Dimitriadis1, Panayota Mitrou, Vaia Lambadiari
12nd Department of Internal Medicine, Research Institute and Diabetes Center, Athens University Medical School, Attikon University Hospital, Haidari, Greece. gdimi@ath.forthnet.gr
Diabetes Research and Clinical Practice
|August 26, 2011
Summary
Insulin significantly impacts carbohydrate, lipid, and protein metabolism in muscle and adipose tissue. It promotes nutrient synthesis, acting as a key anabolic hormone.
Area of Science:
- Endocrinology
- Metabolic Biochemistry
Background:
- Insulin is a critical metabolic hormone regulating glucose homeostasis.
- Understanding insulin's multifaceted roles in nutrient metabolism is essential for metabolic research.
Purpose of the Study:
- To comprehensively outline the major effects of insulin on carbohydrate, lipid, and protein metabolism.
- To elucidate insulin's anabolic functions in key tissues like muscle and adipose tissue.
Main Methods:
- Literature review and synthesis of established knowledge on insulin signaling pathways.
- Analysis of insulin's impact on key enzymes and transport processes in metabolic pathways.
Main Results:
- Insulin enhances glucose transport, glycolysis, and glycogen synthesis while inhibiting glycogenolysis.
- Insulin suppresses lipolysis, stimulates fatty acid and triglyceride synthesis, and promotes triglyceride uptake.
- Insulin increases amino acid transport and protein synthesis while decreasing protein degradation.
Conclusions:
- Insulin exhibits profound anabolic effects across carbohydrate, lipid, and protein metabolism.
- These combined effects underscore insulin's central role in promoting nutrient storage and tissue synthesis.
Related Concept Videos
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...